Navigation Links
Brain-injury rehabilitation depends on acetylcholine circuitry

The ability of the brain to recover from such injury as stroke or trauma depends on a particular circuitry of neurons that "talk" to one another using the brain chemical acetylcholine, researchers led by James Conner and Mark Tuszynski in the Neural repair Group at UCSD have discovered. Their finding in rats could help enhance rehabilitation to recover from such injuries by leading to the development of drugs or other treatments to enhance the "cholinergic system."

The researchers said that their finding that the cholinergic system is involved in brain recovery is particularly intriguing in light of the fact that deficits in the system have been associated with aging, Alzheimer's disease, and traumatic brain injury.

Researchers have long believed that rehabilitation from brain injury causes a rewiring, or plasticity, of brain circuitry--called a "reorganization of cortical motor representations"--to reestablish connections that control muscles. However, the specific type of brain circuitry on which this plasticity depended was not known.

Conner and his colleagues were guided in their experiments by earlier studies showing that the cholinergic system in a region called the basal forebrain was associated with normal learning of motor control.

To determine whether this same system also played a role in rehabilitation from brain injury, they first taught rats to reach for food pellets with their forepaws. In one group of animals, they then used a toxin to specifically eliminate cholinergic nerves connecting to the motor and sensory regions of the animals' cortex. The other control group received a sham injection. The researchers then used electrical probes to create small lesions in the rats' brain region responsible for controlling limb movement.

They then gave the rats rehabilitation training. The control group of rats recovered about 55% of the deficit in their reaching ability, while the rats lacking a cholinergic system recove
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Fats fate depends on its source
2. New study to explore cellular circuitry
3. Zinc plays important role in brain circuitry
4. Common algae helps illustrate mammalian brain electrical circuitry
Post Your Comments:
(Date:7/23/2015)... July 23, 2015 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... 2015 was $4.5 million, a decrease of 33% compared to ... in the second quarter of 2015 was $0.3 million, or ... $0.04 per diluted share, in the same period a year ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... Irvine, Calif., Nov. 21, 2011 UC Irvine and Italian ... of anandamide a natural, marijuana-like chemical in the body ... Louise Turner Arnold Chair in the Neurosciences, the team identified ... sites within the cell where enzymes break it down. They ...
... Log and lumber exports from Washington, Oregon, northern California, and ... the total exports of 2010 according to the U.S. Forest ... shipments to China are the main driver of the hike ... Xiaoping Zhou, a research economist with the station. "The log ...
... with 43 of the companies honored by Thomson Reuters ... a record year of expansion, fueled by businesses, increased ... "The organizations that continue to surge ahead ... innovate," said Andy Zynga, Chief Executive Officer of NineSigma, ...
Cached Biology News:UCI-led team finds new way to boost potency of marijuana-like chemical in body 2West coast log, lumber exports in first 9 months of 2011 surpass 2010 totals 2West coast log, lumber exports in first 9 months of 2011 surpass 2010 totals 3Surging Demand for Innovation Services Leads to Record Expansion for NineSigma 2Surging Demand for Innovation Services Leads to Record Expansion for NineSigma 3
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... helped by hearing aids achieved significant and sometimes profound ... hybrid cochlear implant devices, according to a new multicenter ... In the study, described online ahead of ... 10 medical centers and private clinics in ...
(Date:7/28/2015)... , July 21, 2015 ... has announced the addition of the "Analysis ... report to their offering. Globally, flow ... including immuno-phenotyping, cell proliferation, cancer, and stem cells. ... clinical applications primarily because of demand from underdeveloped ...
(Date:7/28/2015)... , July 28, 2015 Deerfield Management Company, ... Innovations Fund, L.P., which will invest in groundbreaking advancements ... genetic diseases, cancer, and orphan diseases. The venture capital ... how therapeutics are developed and improve the way healthcare ... of the largest healthcare-focused venture funds in the sector, ...
(Date:7/28/2015)... 28, 2015  Moerae Matrix Inc. announced today ... trial with MMI-0100, a first-in-class inhibitor of MAPKAP ... pulmonary disorders characterized by inflammation and fibrosis.  The ... , is a double-blind, two-way cross-over design ... and tolerability of MMI-0100 when given via inhalation ...
Breaking Biology Technology:Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... Mersana, a cancer,therapeutics company, announced today that Timothy ... Officer., "We are thrilled that Tim is now ... President and CEO at Mersana. "His extensive leadership in,oncology ... an,ideal match for Mersana. In addition to the important ...
... CuraGen Corporation,(Nasdaq: CRGN ) announced today that ... present at the BIO CEO & Investor Conference,on Wednesday, ... Access to a live webcast of the presentation ... the webcast will be accessible,beginning one hour after the ...
... at 2008 BIO CEO & Investor conference at the Waldorf-Astoria ... on Tuesday, February 12 at 1:15 PM (Eastern), NEW ... A. Bianco, M.D., President and CEO of Cell,Therapeutics, Inc. (CTI) ... Company,s sales and marketing strategy intended to grow Zevalin(R),(Ibritumomab Tiuxetan) ...
Cached Biology Technology:Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 3Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 4Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 5
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
BACE (CT) rabbit polyclonal antibody...
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
Biology Products: